News

Net profit of IOL Chemicals & Pharmaceuticals rose 89.80% to Rs 64.40 crore in the quarter ended June 2026 as against Rs 33.93 crore during the previous quarter ended June 2025. Sales rose 37.08% to Rs 756.26 crore in the quarter ended June 2026 as against Rs 551.69 crore during the previous quarter ended June 2025. ParticularsQuarter EndedJun. 2026Jun. 2025% Var. Sales756.26551.69 37 OPM %13.6811.26 - PBDT108.0365.28 65 PBT86.6945.51 90 NP64.4033.93 90 Powered by Capital Market - Live News

IOL Chemicals & Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 10 August 2026.

IOL Chemicals & Pharmaceuticals announced that the Annual General Meeting(AGM) of the company will be held on 2 September 2026.

Net profit of IOL Chemicals & Pharmaceuticals rose 69.19% to Rs 53.16 crore in the quarter ended March 2026 as against Rs 31.42 crore during the previous quarter ended March 2025. Sales rose 17.37% to Rs 619.45 crore in the quarter ended March 2026 as against Rs 527.78 crore during the previous quarter ended March 2025.For the full year,net profit rose 36.18% to Rs 137.64 crore in the year ended March 2026 as against Rs 101.07 crore during the previous year ended March 2025. Sales rose 11.54% to Rs 2319.06 crore in the year ended March 2026 as against Rs 2079.21 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales619.45527.78 17 2319.062079.21 12 OPM %14.9311.89 -11.609.73 - PBDT91.1063.25 44 275.80209.95 31 PBT70.8144.70 58 195.57137.96 42 NP53.1631.42 69 137.64101.07 36 Powered by Capital Market - Live News

IOL Chemicals & Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 20 May 2026.